Keros Therapeutics Inc (KROS) Rapporto sugli Utili - Previsioni e Surprise Ratio

Pubblicita'

Storico dei ricavi trimestrali

Data del prossimo reportAug 5, 2024

Stimato per Q2 24:$-1.26

Cambiamenti implicati per il Q1 24:+4.13%

Cambiamenti implicati per il Q2 23:-0.79%

Periodo Bilanci	Data Riportata	EPS / Previsioni	Sorpresa
Q1 24	May 8, 2024	$-1.21 / $-1.31	$0.1 / 7.63%
Q4 23	Feb 28, 2024	$-1.34 / $-1.38	$0.04 / 2.9%
Q3 23	Nov 6, 2023	$-1.33 / $-1.34	$0.01 / 0.75%
Q2 23	Aug 7, 2023	$-1.27 / $-1.34	$0.07 / 5.22%
Q1 23	May 4, 2023	$-1.26 / $-1.13	$-0.13 / -11.5%
Q4 22	Mar 3, 2023	$-1.09 / $-1.12	$0.03 / 2.68%
Q3 22	Nov 3, 2022	$-0.92 / $-1.26	$0.34 / 26.98%
Q2 22	Aug 4, 2022	$-1.13 / $-1.07	$-0.06 / -5.61%

Fornitori di Dati: Xignite Logo